Prosecution Insights
Last updated: October 02, 2026

Examiner: MOEHLMAN, ANDREW TERRY

Tech Center 1600 • Art Units: 1628 1655

This examiner grants 66% of resolved cases

Analysis

Andrew Terry Moehlman is an examiner in Tech Center 1600, specifically within Art Unit 1628. He has 98 resolved cases, providing a focused dataset for analysis. His allowance rate is 66.3 percent, representing a high grant frequency for applications on his docket.

The data shows a very high interview lift of 61.0 percent. This suggests that conducting an interview can dramatically improve the likelihood of an allowance compared to the 66.3 percent baseline. For practitioners in Art Unit 1628, this lift indicates that verbal negotiation is an exceptionally valuable tool.

The median days to allowance for this examiner is 1193. This figure helps applicants set expectations for the length of the prosecution process. Although the 98 resolved cases form a smaller sample size, the 61.0 percent interview lift remains a key metric for developing a successful strategy with this examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

66.3%
Allow Rate
+6.3% vs TC avg
139
Total Applications
+61.0%
Interview Lift
1193
Avg Prosecution Days
Based on 98 resolved cases, 2023–2026

Rejection Statute Breakdown

7.4%
§101 Eligibility
13.8%
§102 Novelty
35.3%
§103 Obviousness
30.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18031505 SELF-ASSEMBLING URICASE FUSION PEPTIDES Final Rejection University of Florida Research Foundation, Incorporated
18820925 PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA Non-Final OA Genentech, Inc.
18843065 USE OF A COMPOSITION FOR MANAGING POSTPRANDIAL GLUCOSE RESPONSE AND ASSOCIATED DISORDERS Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
18262338 Gut Microbiome as a Predictive Biomarker of Outcomes for Chimeric Antigen Receptor T-Cell Therapy Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
17788239 BACTERIAL CONSORTIUM COMPRISING AT LEAST ONE BACILLUS AND LACTOBACILLUS STRAIN FOR GLUTEN DEGRADATION Non-Final OA Evonik Operations GmbH
17801033 DEVICE FOR EVALUATING STATE OF SAMPLE, SYSTEM CONTAINING SAME, METHOD FOR EVALUATING STATE OF SAMPLE AND LACTATE DEHYDROGENASE USED THEREFOR Final Rejection KIKKOMAN CORPORATION
17277617 PLANT PROTEIN AND ITS METHOD OF PREPARATION Non-Final OA ROQUETTE FRERES
18688617 METHODS OF PRODUCING HUMAN MILK OLIGOSACCHARIDES AND COMPOSITIONS THEREOF Non-Final OA Amyris, Inc.
18187797 Method for Forming Fungi Fermentation Product Containing N-Acetylglucosamine to Convert Cancer Cells into Normal Cells Through Mesenchymal Epithelial Transition Mechanism Final Rejection Kun-Lin Yang

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month